IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $476,306,000 | -20.5% | 10,594 | 0.0% | 0.01% | -28.6% |
Q4 2020 | $598,985,000 | +19.2% | 10,594 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $502,685,000 | -19.5% | 10,594 | 0.0% | 0.01% | -22.2% |
Q2 2020 | $624,622,000 | +24.7% | 10,594 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $500,884,000 | -21.7% | 10,594 | 0.0% | 0.01% | +12.5% |
Q4 2019 | $639,984,000 | +0.8% | 10,594 | 0.0% | 0.01% | -11.1% |
Q3 2019 | $634,687,000 | -6.8% | 10,594 | 0.0% | 0.01% | -10.0% |
Q2 2019 | $680,876,000 | +4.9% | 10,594 | -40.2% | 0.01% | +42.9% |
Q3 2016 | $649,114,000 | -64.9% | 17,716 | -80.7% | 0.01% | -65.0% |
Q2 2016 | $1,847,955,000 | +978.7% | 91,893 | +2072.4% | 0.02% | +900.0% |
Q1 2016 | $171,315,000 | -34.6% | 4,230 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $261,964,000 | – | 4,230 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |